Evidence mapPaperPMID 33953548Full record

ReviewPatient preference and adherence2021

Medication Adherence Interventions for Cardiovascular Disease in Low- and Middle-Income Countries: A Systematic Review.

Oluwabunmi Ogungbe, Samuel Byiringiro, Adeola Adedokun-Afolayan, Stella M Seal, Cheryl R Dennison Himmelfarb, Patricia M Davidson, Yvonne Commodore-Mensah

Open access · goldAbstract readReview
In one paragraph

Review in Patient preference and adherence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Atherosclerotic cardiovascular disease landscape in Singapore.Frontiers in cardiovascular medicine · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Oluwabunmi OgungbeJohns Hopkins University School of Nursing, Baltimore, MD, USA.ORCID 0000-0003-1813-0906
Samuel ByiringiroJohns Hopkins University School of Nursing, Baltimore, MD, USA.ORCID 0000-0001-9165-0348
Adeola Adedokun-AfolayanSchool of Public Health, Louisiana State University, Shreveport, LA, USA.ORCID 0000-0003-4107-616X
Stella M SealWilliam H. Welch Medical Library, Johns Hopkins University and Medicine, Baltimore, MD, USA.ORCID 0000-0003-2838-4168
Cheryl R Dennison HimmelfarbJohns Hopkins University School of Nursing, Baltimore, MD, USA.ORCID 0000-0003-1918-4316
Patricia M DavidsonJohns Hopkins University School of Nursing, Baltimore, MD, USA.ORCID 0000-0003-0299-6289
Yvonne Commodore-MensahJohns Hopkins University School of Nursing, Baltimore, MD, USA.ORCID 0000-0002-5054-3025
Johns Hopkins University · USLouisiana State University in Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe burden of cardiovascular diseases (CVD) is high in low- and middle-income countries (LMICs). Medications are integral to the management and control of CVD; however, suboptimal adherence impacts health outcomes. This systematic review aims to critically examine interventions targeted at improving medication adherence among persons with CVD in LMICs.

methodsIn this systematic review, we searched online databases PubMed, Embase, and CINAHL for studies that evaluated a medication adherence intervention for CVD, reported adherence as an outcome measure, were conducted in LMICs and reported the strategy or tool used to measure adherence. We included articles published in English, available in full text, peer-reviewed, and published between 2010 and 2020.

resultsWe included 45 articles in this review. The majority of the studies implemented counseling and educational interventions led by nurses, pharmacists, or community health workers. Many of the studies delivered medication-taking reminders in the form of phone calls, text messages, short message services (SMS), and in-phone calendars. Multi-component interventions were more effective than unifocal interventions. Interventions involving technology, such as mobile phone calls, electronic pillboxes, and interactive phone SMS reminders, were more effective than generic reminders. The outcomes reported in the studies varied based on the complexity and combination of strategies. When interventions were implemented at both the patient level, such as reminders, and at the provider level, such as team-based care, the effect on medication adherence was larger.

conclusionIn LMICs, medication adherence interventions among persons with CVD included a combination of patient education, reminders, fixed-dose combination therapy and team-based care approach were generally more effective than singular interventions. Among patients who had CVD, the medication adherence interventions were found to be moderately effective. Future studies focusing on improving medication adherence in LMICs should consider non-physician-led interventions and appropriately adapt the interventions to the local context.

Indexed as

cardiovascular diseasesLMICsmedication adherencesystematic review

Identifiers

PMID33953548
PMCPMC8092634
OpenAlexW3158170744

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.